RESULTS	Median overall survival was significantly longer in patients with low ERCC1 expression tumors ( 61.6 weeks ; 95 % confidence interval , 42.4-80 .7 weeks ) compared to patients with high expression tumors ( 20.4 weeks , 95 % confidence interval , 6.9-33 .9 weeks ) .\